Overview

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion

Status:
Unknown status

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the effectiveness, safety and tolerability of consistent dosages of the study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven) administrated intravenously for 7 days.

Phase:

Phase 2

Details

Lead Sponsor:

Xijing Hospital

Treatments:

Hydroxyethyl Starch Derivatives